Celcuity Inc. (CELC)
NASDAQ: CELC · IEX Real-Time Price · USD
21.76
+3.60 (19.82%)
Mar 28, 2024, 3:43 PM EDT - Market open
Celcuity Market Cap
Celcuity has a market cap or net worth of $458.32 million as of March 28, 2024. Its market cap has increased by 188.98% in one year.
Market Cap
458.32M
Enterprise Value
315.18M
1-Year Change
188.98%
Ranking
Category
Stock Price
$21.76
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $458.32M, an increase of 242.28%. That is a compound annual growth rate of 20.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 553.00M | 30.42% |
Mar 26, 2024 | 424.00M | -1.58% |
Mar 25, 2024 | 430.80M | 0.12% |
Mar 22, 2024 | 430.30M | 0.89% |
Mar 21, 2024 | 426.50M | -0.95% |
Mar 20, 2024 | 430.60M | -1.17% |
Mar 19, 2024 | 435.70M | 0.97% |
Mar 18, 2024 | 431.50M | 0.44% |
Mar 15, 2024 | 429.60M | -0.35% |
Mar 14, 2024 | 431.10M | -0.83% |
Mar 13, 2024 | 434.70M | 0.63% |
Mar 12, 2024 | 432.00M | -0.28% |
Mar 11, 2024 | 433.20M | -3.56% |
Mar 8, 2024 | 449.20M | 3.45% |
Mar 7, 2024 | 434.20M | -1.39% |
Mar 6, 2024 | 440.30M | -0.05% |
Mar 5, 2024 | 440.50M | -1.56% |
Mar 4, 2024 | 447.50M | 6.07% |
Mar 1, 2024 | 421.90M | 12.03% |
Feb 29, 2024 | 376.60M | -1.15% |
Feb 28, 2024 | 381.00M | -1.42% |
Feb 27, 2024 | 386.50M | 4.04% |
Feb 26, 2024 | 371.50M | 0.05% |
Feb 23, 2024 | 371.30M | 2.29% |
Feb 22, 2024 | 363.00M | 4.52% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Aveanna Healthcare Holdings | 471.33M |
Arbutus Biopharma | 465.78M |
KalVista Pharmaceuticals | 465.34M |
Community Health Systems | 464.91M |
Entrada Therapeutics | 462.35M |
Caribou Biosciences | 456.99M |
Larimar Therapeutics | 456.81M |
Pulse Biosciences | 456.07M |